As the potential of GLP-1 agonists for addiction gains traction, big pharma is also starting to take notice, namely the two ...

An Eli Lilly exec said the company’s experimental weight-loss pill could make GLP-1 treatments more accessible worldwide, as ...

Patients being prescribed weight-loss drugs should be required to see a dietitian, the nutrition industry says as ...

At the pace with which the proportion of overweight people is growing, half of Nepal’s adult population will be obese by 2050 ...

Compounded GLP-1s have given rise to a cottage industry offering cheaper weight loss medications to many Americans — but now ...

Pressure is building on BP chief exec Murray Auchincloss (pictured) following reports that Elliott was disappointed with his ...

After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...

Companies in the US, including Novo Nordisk, Boeing and Shein, are forming task forces to address the impact of Donald ...

Compounded GLP-1s have given rise to a cottage industry offering cheaper weight loss medications to many Americans — but now soon they may be unavailable to most.

Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat ...

Mehmet Oz will likely face questions during his confirmation hearing about his past support of expanding the Medicare ...